Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Heart Failure Treatment and Cardiac Amyloidosis
Author(s): Giorgia Panichella , Alberto Aimo , Vincenzo Castiglione , et al Added: 5 months ago

Heart Failure
Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies
Author(s): Silas Ramos Furquim , Maria Tereza Sampaio de Sousa Lira , Deborah de Sá Pereira Belfort , et al Added: 3 days ago

Guidelines & Statements

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 3 weeks ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Heart Failure

Prevention & Chronic Conditions
A Mark Richards
Research Area(s) / Expertise: Job title: Director of the Christchurch Heart Institute
Professor A. Mark Richards MD(Otago) PhD(Otago) FRACP is director of the Christchurch Heart Institute. Dr Richards also holds joint appointments at the University of Otago and the National University of Singapore’s Cardiovascular Research Institute. Research interests Neurohormonal physiology and pathophysiology in cardiovascular health and disease Heart Failure Acute Coronary Syndromes… View more
Job title: Professor of Medicine
Thomas Kahan
Dr Thomas Kahan is Senior consultant in cardiolgy at the Department of cardiology, Danderyd University Hospital Dr Kahan is on the Editorial Board of European Cardiology Review. Research Interests Neurohormonal control of blood pressure and cardiac function in man. Specifically, we study how the sympatho-adrenal mechanisms and the renin-angiotensin-aldosterone system influence… View more
HFSA 25: The INTEGRA-D Trial
Author(s): Nir Uriel Added: 2 months ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more

Heart Failure
Treatment of Hypertrophic Cardiomyopathy with Dr Tiku Owens
Author(s): Anjali T Owens Added: 2 months ago
Navigate the rapidly evolving treatment landscape for hypertrophic cardiomyopathy with Dr Anjali Tiku Owens, a renowned expert in inherited cardiovascular diseases and advanced heart failure.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, explores both established and emerging therapeutic approaches for obstructive and non… View more

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Vijay Chopra , Javed Butler , Dinesh Khullar , et al Start date: Nov 17, 2025
Breakthrough Mineralocorticoid Receptor Antagonists in Cardiovascular Care brings together renowned cardiovascular experts Dr Vijay Chopra, Dr Javed Butler, Dr Dinesh Khullar, and Prof John McMurray to address critical challenges in heart failure management and hypertension treatment. This comprehensive session explores innovative approaches to mineralocorticoid receptor antagonist (MRA) therapy,… View more

Heart Failure

Prevention & Chronic Conditions
Job title: Head of the Cardiovascular Clinical Pharmacology Laboratory